SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-122982
Filing Date
2023-12-04
Accepted
2023-12-04 06:06:24
Documents
15
Period of Report
2023-12-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332071d1_8k.htm   iXBRL 8-K 28495
2 EXHIBIT 99.1 tm2332071d1_ex99-1.htm EX-99.1 15318
3 GRAPHIC tm233207d1_ex99-1img01.jpg GRAPHIC 2676
  Complete submission text file 0001104659-23-122982.txt   274417

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zura-20231204.xsd EX-101.SCH 3495
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20231204_def.xml EX-101.DEF 26908
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20231204_lab.xml EX-101.LAB 36974
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20231204_pre.xml EX-101.PRE 25532
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2332071d1_8k_htm.xml XML 5077
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 231461212
SIC: 2836 Biological Products, (No Diagnostic Substances)